101 studies found for:
"Acromegaly"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance
|
||||
| 2 | Unknown † |
Lanreotide Levels in Acromegaly
|
||||
| 3 | Recruiting |
The Treatment and Natural History of Acromegaly
|
||||
| 4 | Completed |
Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly
|
||||
| 5 | Recruiting |
A Prospective Study of Outcome After Therapy for Acromegaly
|
||||
| 6 | Unknown † |
Ultrasound Guided Sandostatin LAR Injection in Acromegaly
|
||||
| 7 | Completed |
Surgical Versus Medical Treatment of Acromegaly
|
||||
| 8 | Not yet recruiting |
Epidemiology of Acromegaly
|
||||
| 9 | Completed |
Fractionated Stereotactic Radiotherapy in Patients With Acromegaly
|
||||
| 10 | Completed |
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
|
||||
| 11 | Active, not recruiting |
An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
|
||||
| 12 | Recruiting |
Efficacy and Safety of Octreolin for Acromegaly
|
||||
| 13 | Active, not recruiting |
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
|
||||
| 14 | Terminated |
Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
|
||||
| 15 | Recruiting |
Study of Heart Effects When Growth Hormone (GH) is Used for Growth Hormone Deficiency (GHD) Following Cure of Acromegaly
|
||||
| 16 | Completed |
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
|
||||
| 17 | Not yet recruiting |
Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects
|
||||
| 18 | Completed |
Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
|
||||
| 19 | Active, not recruiting |
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
|
||||
| 20 | Completed |
Acute Application of Pegvisomant and Octreotide in Acromegaly
|
† Indicates status has not been verified in more than two years
